Login      Register

Featured Term

Search Industry & Public Companies

Angiotech Pharmaceuticals, Inc - ANPMF - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Angiotech Pharmaceuticals, Inc - SIC # 3845

Ticker	Exchange	SIC #	Website	Latest Ticker
ANPMF	Over the counter	3845	http://www.angiotech.com	25.00 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Angiotech Pharmaceuticals, Inc ANGIOTECH PHARMACEUTICALS INC Financials - Apr 3rd, 2013 11:04 am ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - Mar 28th, 2013 8:28 am ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial - Mar 26th, 2013 8:02 am ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Ob - Mar 19th, 2013 2:42 am ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers - Nov 15th, 2012 4:04 am ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers - Nov 14th, 2012 7:42 pm ANGIOTECH PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report - Nov 14th, 2012 2:54 pm ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Ob - Sep 20th, 2012 2:33 pm ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi - Aug 16th, 2012 12:37 pm ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - Aug 14th, 2012 3:06 pm Cardiome Pharma says CEO Janzen left the company - Jul 3rd, 2012 1:48 pm ANGIOTECH PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - May 15th, 2012 11:17 am View All Current Headlines >>